Electroencephalography (EEG) is a clinical technique used to measure the electrical activity of the brain. It works by placing several electrodes on the scalp that measure the electrical patterns produced by neurons in different parts of the brain. The recorded signals are typically displayed as a graph, allowing researchers and clinicians to evaluate the underlying brain activity in a given region. EEG has been used for decades to diagnose neurological diseases and to assess the effects of drugs, disease processes, and treatments. It can also be used for research in fields such as cognitive and affective neuroscience. The EEG test alone does not give a definitive diagnosis. It's most effective when used in conjunction with other tests that show how the brain is functioning. EEG readings can be used to identify brainwave abnormalities, diagnose epilepsy and other seizure disorders, measure sleep patterns, detect whether the brain is impaired after a stroke, and evaluate brain damage after severe head trauma. In some cases, it can even detect differences in brainwave patterns that suggest early indications of cognitive decline (such as Alzheimer's) before other tests can. EEG is also useful in understanding cognitive processes such as learning and memory. It can show the presence of brain areas that are activated during cognitive tasks, and can be used to evaluate different types of learning strategies. EEG can also be used to assess the effectiveness of treatments for conditions such as ADHD and autism. EEG is noninvasive, relatively inexpensive, and relatively safe. The risk of infection is low, and the electrodes are usually placed on the scalp after shaving and cleaning a small area. The procedure typically takes between 30 minutes to one hour to complete.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States